Patents by Inventor Gregory Galyanov

Gregory Galyanov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230256147
    Abstract: A system for calculating cardiac output of a patient on an extracorporeal blood oxygenation circuit, such as veno-venous extracorporeal membrane oxygenation, includes determining (i) a first arterial carbon dioxide content or surrogate and (ii) a first carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to the first removal rate of carbon dioxide from the blood; establishing a second removal rate of carbon dioxide from the blood in the oxygenator in the extracorporeal blood oxygenation circuit; determining (i) a second arterial carbon dioxide content or surrogate and (ii) a second carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to the second removal rate of carbon dioxide from the blood; and calculating a cardiac output of the patient corresponding to a blood flow rate through the extracorporeal blood oxygenation circuit, the first arterial carbon dioxide content or surrogate,
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20230248887
    Abstract: A system for calculating cardiac output of a patient on an extracorporeal blood oxygenation circuit, such as veno-venous extracorporeal membrane oxygenation, includes determining (i) a first arterial carbon dioxide content or surrogate and (ii) a first carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to the first removal rate of carbon dioxide from the blood; establishing a second removal rate of carbon dioxide from the blood in the oxygenator in the extracorporeal blood oxygenation circuit; determining (i) a second arterial carbon dioxide content or surrogate and (ii) a second carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to the second removal rate of carbon dioxide from the blood; and calculating a cardiac output of the patient corresponding to a blood flow rate through the extracorporeal blood oxygenation circuit, the first arterial carbon dioxide content or surrogate,
    Type: Application
    Filed: April 17, 2023
    Publication date: August 10, 2023
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20230211060
    Abstract: A system for calculating cardiac output (CO) of a patient undergoing veno-arterial extracorporeal oxygenation includes measuring first oxygenated blood flow rate by a pump in the extracorporeal blood oxygenation circuit as introduced into an arterial portion of the patient circulation system and a corresponding arterial oxygen saturation, then changing the pump flow rate, such as decreasing, to produce a corresponding change in arterial oxygen saturation (wherein such change is outside of normal operating variances, operating errors or drift), which change in the arterial oxygen saturation is measured. From the first flow rate and the second flow rate along with the corresponding measured arterial oxygen saturation, the CO of the patient can be calculated, without reliance upon a measure of venous oxygen saturation.
    Type: Application
    Filed: March 13, 2023
    Publication date: July 6, 2023
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Patent number: 11654218
    Abstract: A system for calculating cardiac output of a patient on an extracorporeal blood oxygenation circuit includes determining the cardiac output corresponding to a blood flow rate through an extracorporeal blood oxygenation circuit, a first arterial carbon dioxide content or surrogate, a first carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to a first removal rate of carbon dioxide from the blood; a second arterial carbon dioxide content or surrogate and a second carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to a second removal rate of carbon dioxide from the blood.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: May 23, 2023
    Assignee: Transonic Systems Inc.
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Patent number: 11633525
    Abstract: A system for calculating cardiac output (CO) of a patient undergoing veno-arterial extracorporeal oxygenation includes measuring first oxygenated blood flow rate by a pump in the extracorporeal blood oxygenation circuit as introduced into an arterial portion of the patient circulation system and a corresponding arterial oxygen saturation, then changing the pump flow rate, such as decreasing, to produce a corresponding change in arterial oxygen saturation (wherein such change is outside of normal operating variances, operating errors or drift), which change in the arterial oxygen saturation is measured. From the first flow rate and the second flow rate along with the corresponding measured arterial oxygen saturation, the CO of the patient can be calculated, without reliance upon a measure of venous oxygen saturation.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: April 25, 2023
    Assignee: Transonic Systems Inc.
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20230036473
    Abstract: A system and method for identifying a disruption of a flow from an extracorporeal circuit to a patient circulatory system, such as a venous needle dislodgement or an access-bloodline separation, is based on flow rate data of the extracorporeal circuit. A patient contribution to the flow rate data can be identified as a harmonic and monitored to assess the presence of the disruption. The system can identify an inharmonic change, such as a spike, in the flow rate in the extracorporeal circuit, wherein the inharmonic change can be used alone or in conjunction with the identified harmonic to assess the existence of the disruption. The system can employ the spike in a blood flow rate as well as a spike in a dialysate flow rate fluidly connected to the extracorporeal circuit, wherein the spike can be used to identify the disruption.
    Type: Application
    Filed: April 5, 2022
    Publication date: February 2, 2023
    Inventors: Nikolai M. Krivitski, Gregory Galyanov, Cornelis J. Drost
  • Publication number: 20230036866
    Abstract: A system and method for identifying a disruption of a flow from an extracorporeal circuit to a patient circulatory system is based on flow rate data, such as from a venous line of the extracorporeal circuit. A patient contribution to the flow rate data is identified and monitored to assess a disruption of the extracorporeal circuit and the patient circulatory system, or access device. A spectrum analysis can be performed on the flow rate data to identify a harmonic corresponding to the patient contribution, wherein a change in or disappearance of the identified harmonic can be used to identify a disruption of the flow.
    Type: Application
    Filed: July 28, 2021
    Publication date: February 2, 2023
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20220409791
    Abstract: A system for calculating cardiac output of a patient on an extracorporeal blood oxygenation circuit includes measuring first oxygenated blood flow rate by a pump in the extracorporeal circuit and a corresponding arterial oxygen saturation and recirculation in the extracorporeal circuit, then changing the pump flow rate, such as decreased, to produce a corresponding change in arterial oxygen saturation (wherein such change is outside of normal operating variances or drift), which change in the arterial oxygen saturation and recirculation are measured. From the first flow rate and the second flow rate along with the corresponding measured recirculation and the arterial oxygen saturation, the CO of the patient can be calculated, without reliance upon a measure of venous oxygen saturation. The system also includes an accommodation of oxygenation by the lungs of the patient during the extracorporeal blood oxygenation.
    Type: Application
    Filed: August 31, 2022
    Publication date: December 29, 2022
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Patent number: 11439735
    Abstract: A system for calculating cardiac output of a patient on an extracorporeal blood oxygenation circuit includes measuring first oxygenated blood flow rate by a pump in the extracorporeal circuit and a corresponding arterial oxygen saturation and recirculation in the extracorporeal circuit, then changing the pump flow rate, such as decreased, to produce a corresponding change in arterial oxygen saturation (wherein such change is outside of normal operating variances or drift), which change in the arterial oxygen saturation and recirculation are measured. From the first flow rate and the second flow rate along with the corresponding measured recirculation and the arterial oxygen saturation, the CO of the patient can be calculated, without reliance upon a measure of venous oxygen saturation. The system also includes an accommodation of oxygenation by the lungs of the patient during the extracorporeal blood oxygenation.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: September 13, 2022
    Assignee: Transonic Systems Inc.
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20200345915
    Abstract: A system for calculating cardiac output of a patient on an extracorporeal blood oxygenation circuit, such as veno-venous extracorporeal membrane oxygenation, includes determining (i) a first arterial carbon dioxide content or surrogate and (ii) a first carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to the first removal rate of carbon dioxide from the blood; establishing a second removal rate of carbon dioxide from the blood in the oxygenator in the extracorporeal blood oxygenation circuit; determining (i) a second arterial carbon dioxide content or surrogate and (ii) a second carbon dioxide content or surrogate in the blood delivered to the patient after passing the oxygenator corresponding to the second removal rate of carbon dioxide from the blood; and calculating a cardiac output of the patient corresponding to a blood flow rate through the extracorporeal blood oxygenation circuit, the first arterial carbon dioxide content or surrogate,
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20200237989
    Abstract: A system for calculating cardiac output of a patient on an extracorporeal blood oxygenation circuit includes measuring first oxygenated blood flow rate by a pump in the extracorporeal circuit and a corresponding arterial oxygen saturation and recirculation in the extracorporeal circuit, then changing the pump flow rate, such as decreased, to produce a corresponding change in arterial oxygen saturation (wherein such change is outside of normal operating variances or drift), which change in the arterial oxygen saturation and recirculation are measured. From the first flow rate and the second flow rate along with the corresponding measured recirculation and the arterial oxygen saturation, the CO of the patient can be calculated, without reliance upon a measure of venous oxygen saturation. The system also includes an accommodation of oxygenation by the lungs of the patient during the extracorporeal blood oxygenation.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 30, 2020
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20200237992
    Abstract: A system for calculating cardiac output (CO) of a patient undergoing veno-arterial extracorporeal oxygenation includes measuring first oxygenated blood flow rate by a pump in the extracorporeal blood oxygenation circuit as introduced into an arterial portion of the patient circulation system and a corresponding arterial oxygen saturation, then changing the pump flow rate, such as decreasing, to produce a corresponding change in arterial oxygen saturation (wherein such change is outside of normal operating variances, operating errors or drift), which change in the arterial oxygen saturation is measured. From the first flow rate and the second flow rate along with the corresponding measured arterial oxygen saturation, the CO of the patient can be calculated, without reliance upon a measure of venous oxygen saturation.
    Type: Application
    Filed: January 29, 2020
    Publication date: July 30, 2020
    Inventors: Nikolai M. Krivitski, Gregory Galyanov
  • Publication number: 20150316404
    Abstract: The present disclosure provides a method and apparatus for measuring or monitoring oxygenator blood volume of a treatment device such as an oxygenator by analyzing an indicator passing through the oxygenator blood volume. Measuring the oxygenator blood volume can be done externally of the vein or artery, or in tubing leading to a blood treatment system which carries the blood exterior of the body of the patient or within the body of the patient. The present system can also monitor tubing volume of flowing blood upstream or downstream of the blood treatment device. The present system thus provides for measuring the volume of an extracorporeal circuit and creates an opportunity to control circuit performance and give an early warning of clotting to improve the quality of a variety of extracorporeal procedures with the use of relatively simple technology.
    Type: Application
    Filed: May 2, 2014
    Publication date: November 5, 2015
    Applicant: Transonic Systems, Inc.
    Inventors: Nikolai M. Krivitski, Naveen Thuramalla, Gregory Galyanov